type 2 innate lymphoid cells
Showing 1 - 25 of >10,000
Type 2 Innate Lymphoid Cells in Severe Pediatric Asthma
Withdrawn
- Severe Asthma
- Biopsy
- +2 more
-
Paris, FranceHôpital Necker Enfants malades
Nov 7, 2022
Sexual Bias in Type 2 Innate Lymphoid Cells in Asthmatic
Recruiting
- Asthma
- Blood sample collection (one tube)
- Blood sample collection (five tubes)
-
Toulouse, FranceLarrey hospital
May 17, 2022
Dermatitis, Atopic, Dermatitis, Eczema Trial in Hamilton (Benralizumab, Placebo Control)
Completed
- Dermatitis, Atopic
- +9 more
- Benralizumab
- Placebo Control
-
Hamilton, Ontario, CanadaMcMaster Cardio-Respiratory Research Lab
Oct 14, 2021
Innate Lymphoid Cells in Peripheral Blood in ALS
Terminated
- Amyotrophic Lateral Sclerosis
- Blood draw
-
Ann Arbor, MichiganUniversity of Michigan
Dec 22, 2021
Recurrent Acute Lymphoblastic Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Prolymphocytic Leukemia Trial
Recruiting
- Recurrent Acute Lymphoblastic Leukemia
- +15 more
- Anti-CD19/CD20/CD22 CAR T-Cells
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 4, 2022
Immune System Trial in Reus (Almond intervention, Control)
Recruiting
- Immune System
- Almond intervention
- Control
-
Reus, Tarragona, SpainIISPV
Oct 5, 2021
Innate Immunity in Eosinophilic Esophagitis
Completed
- Eosinophilic Esophagitis
- Endoscopy
-
Paris, FranceNecker-Enfants Malades Hospital
Apr 13, 2021
Relapsed or Refractory Hodgkin Lymphoma, Peripheral T Cell Lymphoma Trial (AFM13, AB-101, Cyclophosphamide)
Not yet recruiting
- Relapsed or Refractory Hodgkin Lymphoma
- Peripheral T Cell Lymphoma
- AFM13
- +4 more
- (no location specified)
May 30, 2023
Osteogenesis Imperfecta, Osteogenesis Imperfecta Type III Trial (Bone marrow-derived mesenchymal stromal cells (MSCs))
Not yet recruiting
- Osteogenesis Imperfecta
- Osteogenesis Imperfecta Type III
- Bone marrow-derived mesenchymal stromal cells (MSCs)
- (no location specified)
Nov 28, 2022
From Skin Fibroblasts to Neural Stem Cells to Investigate in
Active, not recruiting
- Diabetes Mellitus, Type 2
- +5 more
- Skin biopsy
-
Roma, ItalyMingrone Geltrude
Mar 8, 2023
Acute Lymphoid Leukemia, B-Cell Leukemia, Leukemia, Lymphocytic, B Cell Trial run by the National Cancer Institute (NCI)
Not yet recruiting
- Acute Lymphoid Leukemia
- +4 more
- fludarabine
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
B Acute Lymphoblastic Leukemia Trial in Duarte (drug, procedure, other)
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- Autologous Anti-CD19 CAR-expressing T Lymphocytes
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 30, 2023
Visualizing Beta Cells After Bariatric Surgery
Recruiting
- Type 2 Diabetes Mellitus
- 68Ga-exendin PET/CT
-
Arnhem, Gelderland, Netherlands
- +1 more
Jun 16, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes
-
Houston, TexasM D Anderson Cancer Center
Jul 13, 2022
Acute Lymphoid Leukemia Trial in Spain (ARI-0001 cells)
Recruiting
- Acute Lymphoid Leukemia
- ARI-0001 cells
-
Badalona, Barcelona, Spain
- +9 more
Feb 3, 2022
Acute Lymphoid Leukemia Trial in Philadelphia (huCART19)
Recruiting
- Acute Lymphoid Leukemia
- huCART19
-
Philadelphia, PennsylvaniaChildren's Hospital of Pennsylvania
Jul 21, 2022
Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,
Not yet recruiting
- Prostate Carcinoma
- +3 more
- Bendamustine
- +12 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 17, 2023
PBMC as Biomarkers of Diabetic Cardiomyopathy
Not yet recruiting
- Type 2 Diabetes
- +3 more
- Blood test
- quality of life Questionnaire
-
Bron, FranceHopital Louis Pradel
Dec 13, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Duarte
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Apr 5, 2023
HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1
Recruiting
- HLA-A2 Positive Cells Present
- Refractory Melanoma
- Alpha-type-1 Polarized Dendritic Cells
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 12, 2022
Melanoma Trial in Beijing (OH2 injection, HX008 injection)
Recruiting
- Melanoma
- OH2 injection
- HX008 injection
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Jan 28, 2023
Type 2 Diabetes Trial in Baltimore (Aerobic Exercise Training)
Active, not recruiting
- Type 2 Diabetes Mellitus
- Aerobic Exercise Training
-
Baltimore, MarylandBaltimore VA Medical Center
Feb 28, 2022
B Cell Acute Lymphoblastic Leukemia (B-ALL), B Lineage Lymphoblastic Lymphoma Trial (Autologous Humanized CD19-Directed Chimeric
Not yet recruiting
- B Cell Acute Lymphoblastic Leukemia (B-ALL)
- B Lineage Lymphoblastic Lymphoma
- Autologous Humanized CD19-Directed Chimeric Antigen Receptor T-Cells (huCART19)
- (no location specified)
Jul 27, 2022
Diabetes, Type 2 Trial in Washington (Semaglutide, Placebos)
Recruiting
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebos
-
Washington, District of ColumbiaThe GW Medical Faculty Associates
Mar 21, 2022
B-cell Non Hodgkin Lymphoma, B-cell Chronic Lymphocytic Leukemia Trial in Milwaukee (Dose Level -1: 0.75x10^6 cells/kg
Recruiting
- B-cell Non Hodgkin Lymphoma
- B-cell Chronic Lymphocytic Leukemia
- Dose Level -1: 0.75x10^6 cells/kg CAR20.19.22 cells
- +3 more
-
Milwaukee, WisconsinMedical College of Wisconsin and Froedtert Hospital
Jul 1, 2022